Page last updated: 2024-09-05

vx-745 and cp 547632

vx-745 has been researched along with cp 547632 in 2 studies

Compound Research Comparison

Studies
(vx-745)
Trials
(vx-745)
Recent Studies (post-2010)
(vx-745)
Studies
(cp 547632)
Trials
(cp 547632)
Recent Studies (post-2010) (cp 547632)
5813519113

Protein Interaction Comparison

ProteinTaxonomyvx-745 (IC50)cp 547632 (IC50)
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0093
Glycogen synthase kinase-3 betaHomo sapiens (human)0.0715
Angiopoietin-1 receptorHomo sapiens (human)0.319
Discoidin domain-containing receptor 2Homo sapiens (human)0.237

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

2 other study(ies) available for vx-745 and cp 547632

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013